K.K. eMind
1xbet 보너스 코드hoku University, National University Corporation
1xbet 보너스 코드 Pharmaceutical Co., Ltd
eMind, Tohoku University, 1xbet 보너스 코드 Otsuka Pharmaceutical Launch Epilepsy Smart Medical Joint Research Project (Phase II) Aiming to Start 1xbet 보너스 코드 Exp1xbet 보너스 코드 Epilepsy Treatment Support System
K.K. eMind, (eMind), Tohoku University School of Medicine (Tohoku University), and 1xbet 보너스 코드 (Otsuka) announce the launch of a collaborative research project using the smartphone application eMind for Medical Research for patients with epilepsy, as part of the Epilepsy Smart Medical Collaborative Research Project (Phase II). This collaborative research aims to contribute to improving the quality of life (QOL) of patients with epilepsy, with the ultimate goal of implementing a technology-driven system to support epilepsy care in society based on the research findings.
Research Background 1xbet 보너스 코드 Progress to Date
In 2021, information 1xbet 보너스 코드 communication devices reached a household penetration rate of over 97%. Among these, smartphones 1xbet 보너스 코드 wearable devices-being the most familiar--are equipped with a wide variety of sensors 1xbet 보너스 코드 functions. The operation logs from these devices are now closely linked to human cognition 1xbet 보너스 코드 behavior.
To support epilepsy patients across physical, mental, 1xbet 보너스 코드 social dimensions, the Epilepsy Smart Medical Collaborative Research Project (Phase I) was established in October 2022 to conduct research applying eMind's proprietary AI prediction technology (Patent No. 6841466), which utilizes data obtained from digital devices, to the field of epilepsy.
Since April 2023, research has been conducted with epilepsy inpatients at Tohoku University Hospital. During their hospitalization for detailed examinations, various biosignals, behavioral data, psychosocial evaluation data, 1xbet 보너스 코드 daily life data collected via the smartphone application eMind for Medical Research have been analyzed using AI. The research focused on developing models for predicting epileptic seizures 1xbet 보너스 코드 inferring psychological states, while also verifying the correlations between physical, mental, 1xbet 보너스 코드 social assessments. As a result of these research activities, a patent related to the seizure prediction model was obtained in May 2024 (Patent No. 7534745), 1xbet 보너스 코드 an international application is currently underway.
The "AnyTalk" feature within the eMind app provides a social support service aimed at maintaining 1xbet 보너스 코드 improving treatment 1xbet 보너스 코드 medication adherence for epilepsy patients. When users input their thoughts 1xbet 보너스 코드 feelings about daily events, they receive supportive 1xbet 보너스 코드 empathetic messages based on psychological insights from qualified psychological supporters (licensed psychologists or certified clinical psychologists) accredited by eMind. This system has been highly rated by patients for its contribution to improving QOL 1xbet 보너스 코드 addressing feelings of loneliness 1xbet 보너스 코드 anxiety. Evaluating 1xbet 보너스 코드 verifying the effectiveness of such psychosocial support is also one of the concrete steps toward real-world implementation.
1xbet 보너스 코드 Theme of the Epilepsy Smart Medical Collaborative 1xbet 보너스 코드 Project (Phase II)
In April 2025, Otsuka joined the Epilepsy Smart Medical Collaborative Research Project (Phase II). Building upon the outcomes of Phase I, this new phase of research will involve applied studies with a stronger focus on real-world implementation, in collaboration with Otsuka's digital solution division. The project aims to continuously develop 1xbet 보너스 코드 validate a system designed to enhance the patient experience. Based on the results of this research, the ultimate goal is to contribute to improving the quality of life (QOL) of epilepsy patients by implementing a technology-driven system to support epilepsy care in society.
Overview of the Epilepsy Smart Medical Collaborative 1xbet 보너스 코드 Project
-Title: Epilepsy Smart Medical Collaborative 1xbet 보너스 코드 Project (Phase II)
-Objective: To support epilepsy patients across physical, mental, 1xbet 보너스 코드 social dimensions through digital devices 1xbet 보너스 코드 AI, contributing to the improvement of their QOL.
-Principal Investiga1xbet 보너스 코드rs
- Hidenori Endo, Professor, Graduate School of Medicine, 1xbet 보너스 코드hoku University
- Sa1xbet 보너스 코드ru Komura, COO, K.K. eMind
- Koji Onishi, Portfolio Management Office, 1xbet 보너스 코드
-1xbet 보너스 코드 Location: Tohoku University, National University Corporation
-Duration: From April 2025 1xbet 보너스 코드 March 2028